Cargando…
Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis
BACKGROUND: Patients with triple-negative breast cancer (TNBC) present a higher probability of distant metastasis and lack of effective targeted therapy. ETS translocation variant 4 (ETV4) is an ETS (E-26) transcription factor and has been associated with tumor metastasis. However, the clinical and...
Autores principales: | Yuan, Zhong-Yu, Dai, Ting, Wang, Shu-Sen, Peng, Rou-Jun, Li, Xing-Hua, Qin, Tao, Song, Li-Bing, Wang, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196788/ https://www.ncbi.nlm.nih.gov/pubmed/25328406 http://dx.doi.org/10.2147/OTT.S66692 |
Ejemplares similares
-
High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis
por: Yuan, Zhong-Yu, et al.
Publicado: (2014) -
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
por: Ouyang, Mao, et al.
Publicado: (2015) -
Risk factors for distant metastasis of patients with primary triple-negative breast cancer
por: Yao, Yi, et al.
Publicado: (2019) -
A Risk Stratification Model for Predicting Overall Survival and Surgical Benefit in Triple-Negative Breast Cancer Patients With de novo Distant Metastasis
por: Wang, Zheng, et al.
Publicado: (2020) -
A Novel Seven Gene Signature-Based Prognostic Model to Predict Distant Metastasis of Lymph Node-Negative Triple-Negative Breast Cancer
por: Peng, Wenting, et al.
Publicado: (2021)